Asia Medical and Agricultural Laboratory and Research Center Valuation
Is AMARC-F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AMARC-F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AMARC-F (THB2.9) is trading above our estimate of fair value (THB0.89)
Significantly Below Fair Value: AMARC-F is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AMARC-F?
Other financial metrics that can be useful for relative valuation.
What is AMARC-F's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿562.80m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.6x |
Enterprise Value/EBITDA | 9.1x |
PEG Ratio | 1x |
Price to Earnings Ratio vs Peers
How does AMARC-F's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 16.6x | ||
STI Stonehenge Inter | 33x | n/a | ฿1.8b |
BTC Brooker Group | 5x | n/a | ฿4.9b |
BOL Business Online | 19.8x | n/a | ฿5.7b |
UBA Utility Business Alliance | 8.4x | n/a | ฿582.0m |
AMARC-F Asia Medical and Agricultural Laboratory and Research Center | 38.1x | 37.5% | ฿562.8m |
Price-To-Earnings vs Peers: AMARC-F is expensive based on its Price-To-Earnings Ratio (38.1x) compared to the peer average (16.6x).
Price to Earnings Ratio vs Industry
How does AMARC-F's PE Ratio compare vs other companies in the Asian Professional Services Industry?
Price-To-Earnings vs Industry: AMARC-F is expensive based on its Price-To-Earnings Ratio (38.1x) compared to the Asian Professional Services industry average (19.8x).
Price to Earnings Ratio vs Fair Ratio
What is AMARC-F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 38.1x |
Fair PE Ratio | 22.5x |
Price-To-Earnings vs Fair Ratio: AMARC-F is expensive based on its Price-To-Earnings Ratio (38.1x) compared to the estimated Fair Price-To-Earnings Ratio (22.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.